Cargando…

A novel tool for predicting the risk of central lymph node metastasis in patients with papillary thyroid microcarcinoma: a retrospective cohort study

INTRODUCTION: Central lymph node status in papillary thyroid microcarcinoma (PTMC) plays an important role in treatment decision-making clinically, however, it is not easy to predict central lymph node metastasis (CLNM). The present work focused on finding the more rational alternative for evaluatin...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Qian-wen, Gao, Shan, Lv, Xiao, Li, Si-jia, Wang, Bo-fang, Han, Qing-qing, Wang, Yun-peng, Guan, Quan-lin, Gong, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164332/
https://www.ncbi.nlm.nih.gov/pubmed/35655253
http://dx.doi.org/10.1186/s12885-022-09655-5
_version_ 1784720110435434496
author Luo, Qian-wen
Gao, Shan
Lv, Xiao
Li, Si-jia
Wang, Bo-fang
Han, Qing-qing
Wang, Yun-peng
Guan, Quan-lin
Gong, Tao
author_facet Luo, Qian-wen
Gao, Shan
Lv, Xiao
Li, Si-jia
Wang, Bo-fang
Han, Qing-qing
Wang, Yun-peng
Guan, Quan-lin
Gong, Tao
author_sort Luo, Qian-wen
collection PubMed
description INTRODUCTION: Central lymph node status in papillary thyroid microcarcinoma (PTMC) plays an important role in treatment decision-making clinically, however, it is not easy to predict central lymph node metastasis (CLNM). The present work focused on finding the more rational alternative for evaluating central lymph node status while identifying influencing factors to construct a model to predict CLNM incidence. METHODS: In this study, we retrospectively analyzed the typical sonographic and clinicopathologic features of 546 PTMC patients who underwent surgery, among which, the data of 382 patients were recruited in the training cohort and that of 164 patients in the validation cohort. Based on the outcome of the training cohort, significant influencing factors were further identified through univariate analysis and were considered as independent variables in multivariable logistic regression analysis and incorporated in and presented with a nomogram. RESULTS: In total, six independent predictors, including the age, sex, tumor size, multifocality, capsular invasion, Hashimotos thyroiditis were entered into the nomogram. Both internal validation and external validation revealed the favorable discrimination of our as-constructed nomogram. Calibration curves exhibited high consistency. As suggested by decision-curve analyses, the as-constructed nomogram might be applied in clinic. Besides, the model also distinguished patients according to risk stratification. CONCLUSIONS: The novel nomogram containing remarkable influencing factors for CLNM cases was established in the present work. The nomogram can assist clinicians in clinical decision-making.
format Online
Article
Text
id pubmed-9164332
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-91643322022-06-05 A novel tool for predicting the risk of central lymph node metastasis in patients with papillary thyroid microcarcinoma: a retrospective cohort study Luo, Qian-wen Gao, Shan Lv, Xiao Li, Si-jia Wang, Bo-fang Han, Qing-qing Wang, Yun-peng Guan, Quan-lin Gong, Tao BMC Cancer Research INTRODUCTION: Central lymph node status in papillary thyroid microcarcinoma (PTMC) plays an important role in treatment decision-making clinically, however, it is not easy to predict central lymph node metastasis (CLNM). The present work focused on finding the more rational alternative for evaluating central lymph node status while identifying influencing factors to construct a model to predict CLNM incidence. METHODS: In this study, we retrospectively analyzed the typical sonographic and clinicopathologic features of 546 PTMC patients who underwent surgery, among which, the data of 382 patients were recruited in the training cohort and that of 164 patients in the validation cohort. Based on the outcome of the training cohort, significant influencing factors were further identified through univariate analysis and were considered as independent variables in multivariable logistic regression analysis and incorporated in and presented with a nomogram. RESULTS: In total, six independent predictors, including the age, sex, tumor size, multifocality, capsular invasion, Hashimotos thyroiditis were entered into the nomogram. Both internal validation and external validation revealed the favorable discrimination of our as-constructed nomogram. Calibration curves exhibited high consistency. As suggested by decision-curve analyses, the as-constructed nomogram might be applied in clinic. Besides, the model also distinguished patients according to risk stratification. CONCLUSIONS: The novel nomogram containing remarkable influencing factors for CLNM cases was established in the present work. The nomogram can assist clinicians in clinical decision-making. BioMed Central 2022-06-02 /pmc/articles/PMC9164332/ /pubmed/35655253 http://dx.doi.org/10.1186/s12885-022-09655-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Luo, Qian-wen
Gao, Shan
Lv, Xiao
Li, Si-jia
Wang, Bo-fang
Han, Qing-qing
Wang, Yun-peng
Guan, Quan-lin
Gong, Tao
A novel tool for predicting the risk of central lymph node metastasis in patients with papillary thyroid microcarcinoma: a retrospective cohort study
title A novel tool for predicting the risk of central lymph node metastasis in patients with papillary thyroid microcarcinoma: a retrospective cohort study
title_full A novel tool for predicting the risk of central lymph node metastasis in patients with papillary thyroid microcarcinoma: a retrospective cohort study
title_fullStr A novel tool for predicting the risk of central lymph node metastasis in patients with papillary thyroid microcarcinoma: a retrospective cohort study
title_full_unstemmed A novel tool for predicting the risk of central lymph node metastasis in patients with papillary thyroid microcarcinoma: a retrospective cohort study
title_short A novel tool for predicting the risk of central lymph node metastasis in patients with papillary thyroid microcarcinoma: a retrospective cohort study
title_sort novel tool for predicting the risk of central lymph node metastasis in patients with papillary thyroid microcarcinoma: a retrospective cohort study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164332/
https://www.ncbi.nlm.nih.gov/pubmed/35655253
http://dx.doi.org/10.1186/s12885-022-09655-5
work_keys_str_mv AT luoqianwen anoveltoolforpredictingtheriskofcentrallymphnodemetastasisinpatientswithpapillarythyroidmicrocarcinomaaretrospectivecohortstudy
AT gaoshan anoveltoolforpredictingtheriskofcentrallymphnodemetastasisinpatientswithpapillarythyroidmicrocarcinomaaretrospectivecohortstudy
AT lvxiao anoveltoolforpredictingtheriskofcentrallymphnodemetastasisinpatientswithpapillarythyroidmicrocarcinomaaretrospectivecohortstudy
AT lisijia anoveltoolforpredictingtheriskofcentrallymphnodemetastasisinpatientswithpapillarythyroidmicrocarcinomaaretrospectivecohortstudy
AT wangbofang anoveltoolforpredictingtheriskofcentrallymphnodemetastasisinpatientswithpapillarythyroidmicrocarcinomaaretrospectivecohortstudy
AT hanqingqing anoveltoolforpredictingtheriskofcentrallymphnodemetastasisinpatientswithpapillarythyroidmicrocarcinomaaretrospectivecohortstudy
AT wangyunpeng anoveltoolforpredictingtheriskofcentrallymphnodemetastasisinpatientswithpapillarythyroidmicrocarcinomaaretrospectivecohortstudy
AT guanquanlin anoveltoolforpredictingtheriskofcentrallymphnodemetastasisinpatientswithpapillarythyroidmicrocarcinomaaretrospectivecohortstudy
AT gongtao anoveltoolforpredictingtheriskofcentrallymphnodemetastasisinpatientswithpapillarythyroidmicrocarcinomaaretrospectivecohortstudy
AT luoqianwen noveltoolforpredictingtheriskofcentrallymphnodemetastasisinpatientswithpapillarythyroidmicrocarcinomaaretrospectivecohortstudy
AT gaoshan noveltoolforpredictingtheriskofcentrallymphnodemetastasisinpatientswithpapillarythyroidmicrocarcinomaaretrospectivecohortstudy
AT lvxiao noveltoolforpredictingtheriskofcentrallymphnodemetastasisinpatientswithpapillarythyroidmicrocarcinomaaretrospectivecohortstudy
AT lisijia noveltoolforpredictingtheriskofcentrallymphnodemetastasisinpatientswithpapillarythyroidmicrocarcinomaaretrospectivecohortstudy
AT wangbofang noveltoolforpredictingtheriskofcentrallymphnodemetastasisinpatientswithpapillarythyroidmicrocarcinomaaretrospectivecohortstudy
AT hanqingqing noveltoolforpredictingtheriskofcentrallymphnodemetastasisinpatientswithpapillarythyroidmicrocarcinomaaretrospectivecohortstudy
AT wangyunpeng noveltoolforpredictingtheriskofcentrallymphnodemetastasisinpatientswithpapillarythyroidmicrocarcinomaaretrospectivecohortstudy
AT guanquanlin noveltoolforpredictingtheriskofcentrallymphnodemetastasisinpatientswithpapillarythyroidmicrocarcinomaaretrospectivecohortstudy
AT gongtao noveltoolforpredictingtheriskofcentrallymphnodemetastasisinpatientswithpapillarythyroidmicrocarcinomaaretrospectivecohortstudy